Ally Bridge Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-54,743
Closed -$3.97M 38
2021
Q1
$3.97M Hold
54,743
0.76% 30
2020
Q4
$2.37M Buy
+54,743
New +$2.45M 0.41% 27

Other funds holding ORTX

Ally Bridge Group's ORTX Position: Q2 2021 in Review

Ally Bridge Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2021, closing a stake of 54,743 shares — an estimated $3.97M sold.

Ally Bridge Group first reported a position in ORTX in Q4 2020 and held it in 2 quarters. The position peaked at $3.97M in Q1 2021. 85 funds tracked by Wall St. Rank hold ORTX as of Q2 2021.

  • Ally Bridge Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Ally Bridge Group sold 54,743 Orchard Therapeutics plc American Depositary Shares shares in Q2 2021, an estimated $3.97M.
  • Ally Bridge Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2020 and held it in 2 quarters.
  • Ally Bridge Group's Orchard Therapeutics plc American Depositary Shares position peaked at $3.97M in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2021.

Based on Ally Bridge Group's 13F filing for Q2 2021, filed 16 Aug 2021.